Monday, June 15, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 954 of 1,261

  1. US 8003629

    21-substituted progesterone derivatives as new antiprogestational agents

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 23, 2011 · Expires Aug 18, 2031

    granted

  2. US 8003619

    Method of stimulating an immune response and inhibiting expression of a gene using an oligonucleotide

    Alnylam Pharmaceuticals, Inc. · Granted Aug 23, 2011 · Expires Aug 18, 2031

    granted

  3. US 8003660

    Modulators of muscarinic receptors

    Vertex Pharmaceuticals Incorporated · Granted Aug 23, 2011 · Expires Aug 18, 2031

    granted

  4. US 8003406

    Methods for detecting attention-deficit/hyperactivity disorder

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 23, 2011 · Expires Aug 18, 2031

    granted

  5. US 8003785

    Halo-substituted pyrimidodiazepines

    Takeda Pharmaceutical Company Limited · Granted Aug 23, 2011 · Expires Aug 18, 2031

    granted

  6. US 7999071

    Human cytotoxic T-lymphoctye epitope and its agonist eptiope from the non-variable number of tandem repeat sequence of MUC-1

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 16, 2011 · Expires Aug 11, 2031

    granted

  7. US 7999082

    Anti-factor B antibodies

    The Regents of the University of Colorado · Granted Aug 16, 2011 · Expires Aug 11, 2031

    granted

  8. US 7999001

    Antiviral compounds and methods of using thereof

    The United States of America as represented by the Secretary of the Army · Granted Aug 16, 2011 · Expires Aug 11, 2031

    granted

  9. US 7998736

    Adoptive immunotherapy with enhanced T lymphocyte survival

    The United States of America, as represented by the Department of Health and Human Services · Granted Aug 16, 2011 · Expires Aug 11, 2031

    granted

  10. US 7998928

    Method of treatment of type-1 diabetes with a humanin analogue

    The Regents of the University of California · Granted Aug 16, 2011 · Expires Aug 11, 2031

    granted

  11. US 7998490

    Genes of an otitis media isolate of nontypeable Haemophilus influenzae

    The Board of Regents of the University of Oklahoma · Granted Aug 16, 2011 · Expires Aug 11, 2031

    granted

  12. US 7998994

    Solid forms of (1R,2S,3R)-1-(2-(isoxazol-3-yl)-1H-imidazol-4-yl)butane-1,2,3,4-tetraol and methods of their use

    LEXICON PHARMACEUTICALS, INC. · Granted Aug 16, 2011 · Expires Aug 11, 2031

    granted

  13. US 7998684

    Screening method for an agent for treatment of neurodegenerative disease

    Takeda Pharmaceutical Company Limited · Granted Aug 16, 2011 · Expires Aug 11, 2031

    granted

  14. US 7998923

    Bioactivation of particles

    The Regents of the University of California · Granted Aug 16, 2011 · Expires Aug 11, 2031

    granted

  15. US 7998682

    Method for assessing atherosclerosis by measuring expression of FOS or DUSP1 in monocytes

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Aug 16, 2011 · Expires Aug 11, 2031

    granted

  16. US 7998481

    Modulation of NKG2D for treating or preventing solid organ allograft rejection

    The Regents of the University of California · Granted Aug 16, 2011 · Expires Aug 11, 2031

    granted

  17. US 7998992

    Oxazolidinone derivative having inhibitory activity on 11β-hydroxysteroid dehydrogenase type 1

    Institute of Medicinal Molecular Design, Inc. · Granted Aug 16, 2011 · Expires Aug 11, 2031

    granted

  18. US 7998987

    Inhibitors of c-Met and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Aug 16, 2011 · Expires Aug 11, 2031

    granted

  19. US 7999007

    Buffer solutions having selective bactericidal activity against gram negative bacteria and methods of using same

    United Therapeutics Corporation · Granted Aug 16, 2011 · Expires Aug 11, 2031

    granted

  20. US 7999074

    Bacteriocins and novel bacterial strains

    The United States of America, as represented by the Secretary of Agriculture · Granted Aug 16, 2011 · Expires Aug 11, 2031

    granted

  21. US 7999079

    Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins

    The Regents of the University of California · Granted Aug 16, 2011 · Expires Aug 11, 2031

    granted

  22. US 7999077

    IRTA2 antibodies and methods of use

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Aug 16, 2011 · Expires Aug 11, 2031

    granted

  23. US 7999113

    Modulators of cystic fibrosis transmembrane conductance regulator

    Vertex Pharmaceuticals Incorporated · Granted Aug 16, 2011 · Expires Aug 11, 2031

    granted

  24. US 7998957

    Oxabicycloheptanes and oxabicylcoheptenes, their preparation and use

    Lixte Biotechnology, Inc. · Granted Aug 16, 2011 · Expires Aug 11, 2031

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.